Persistent Epithelial Defect

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2010-02-26
Clinical Trial Update: A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects [Phase 2]
The Phase 2 clinical trial evaluating Nexagon for persistent epithelial defect has been withdrawn.